NP / PA
Perez, Denia
Perez, Denia was paid $604K by Medicaid between Apr 2020 and Nov 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoPEREZ, DENIA
PATERSON, NJ 07503
PATERSON, NJ 07503
33aNPI1780949792assigned 07/06/2012
33bProvider typeAdult Health Nurse Practitioner
28Total paid$604K
24GClaims80,162
24DCodes billed62
24AFirst – last monthApr 2020 – Nov 2024
Compared with peers
Next to other Adult Health Nurse Practitioner providers in New Jersey
Rank by total paid#3 of 52
Median peer was paid$2K
This provider vs. median322×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 14,119 | $110K | |
| 2021 | 13,626 | $171K | |
| 2022 | 18,478 | $145K | |
| 2023 | 20,730 | $83K | |
| 2024incomplete | 13,209 | $94K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 12,463 | 8,315 | $341K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 2,716 | 2,330 | $106K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.8% | 584 | 511 | $29K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.5% | 937 | 659 | $27K |
| 99401 | 3.9% | 2,219 | 1,581 | $24K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.0% | 746 | 648 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 1,430 | 1,113 | $8K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 304 | 257 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.0% | 819 | 711 | $6K |
| 90674 | <1% | 264 | 253 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 99 | 99 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,654 | 2,792 | $4K |
50 more codes
| 99443 | <1% | 153 | $3K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 16 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 297 | $3K |
| 99386 | <1% | 58 | $2K | |
| 96127 | <1% | 724 | $2K | |
| 99385 | <1% | 57 | $1K | |
| 99442 | <1% | 77 | $1K | |
| 96160 | <1% | 688 | $1K | |
| 93000 | <1% | 76 | $902.70 | |
| 99490 | Ccm add 20min | <1% | 95 | $787.35 |
| 90686 | <1% | 44 | $745.29 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 579 | $734.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 49 | $721.75 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 58 | $669.39 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 31 | $668.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 372 | $585.12 |
| 99408 | <1% | 502 | $500.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 205 | $326.06 |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 32 | $224.00 |
| 82962 | <1% | 1,296 | $171.04 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 13 | $146.25 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $145.86 |
| 82947 | <1% | 37 | $112.37 | |
| 1160F | <1% | 10,291 | $76.00 | |
| 1126F | <1% | 6,012 | $65.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $43.70 |
| 94760 | <1% | 345 | $23.20 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 4,172 | $0.00 |
| 1159F | 0% | 6,795 | $0.00 | |
| 3050F | 0% | 399 | $0.00 | |
| 3077F | 0% | 125 | $0.00 | |
| 3078F | 0% | 3,154 | $0.00 | |
| 81002 | 0% | 41 | $0.00 | |
| G9931 | Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women | 0% | 148 | $0.00 |
| 3051F | 0% | 53 | $0.00 | |
| 1100F | 0% | 45 | $0.00 | |
| 3074F | 0% | 3,807 | $0.00 | |
| 1125F | 0% | 3,650 | $0.00 | |
| 3044F | 0% | 1,470 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 589 | $0.00 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 1,425 | $0.00 |
| 3079F | 0% | 1,135 | $0.00 | |
| 3017F | 0% | 174 | $0.00 | |
| 3048F | 0% | 654 | $0.00 | |
| 3008F | 0% | 2,716 | $0.00 | |
| 3049F | 0% | 615 | $0.00 | |
| 3075F | 0% | 261 | $0.00 | |
| 36416 | 0% | 55 | $0.00 | |
| 3061F | 0% | 191 | $0.00 | |
| 3060F | 0% | 121 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.